Literature DB >> 8786032

Is human insulin without effect in the diabetic rat?

O Torffvit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786032     DOI: 10.1007/bf00400619

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy.

Authors:  T J Allen; M E Cooper; R C O'Brien; L A Bach; B Jackson; G Jerums
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

2.  Streptozotocin-induced diabetes in the spontaneously hypertensive rat.

Authors:  P Somani; H P Singh; R K Saini; A Rabinovitch
Journal:  Metabolism       Date:  1979-11       Impact factor: 8.694

3.  Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.

Authors:  M E Cooper; J Rumble; R Komers; H C Du; K Jandeleit; S T Chou
Journal:  Diabetes       Date:  1994-10       Impact factor: 9.461

4.  Control of blood glucose levels in the streptozotocin diabetic rat using a long-acting heat-treated insulin.

Authors:  R Rasch
Journal:  Diabetologia       Date:  1979-03       Impact factor: 10.122

5.  The subcutaneous absorption of human and bovine ultralente insulin formulations.

Authors:  P Hildebrandt; A Berger; A Vølund; C Kühl
Journal:  Diabet Med       Date:  1985-09       Impact factor: 4.359

6.  The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.

Authors:  T Soulis-Liparota; M E Cooper; M Dunlop; G Jerums
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

7.  Human, porcine and bovine ultralente insulin: subcutaneous administration in normal man.

Authors:  D R Owens; J P Vora; L G Heding; S Luzio; R E Ryder; J Atiea; T M Hayes
Journal:  Diabet Med       Date:  1986 Jul-Aug       Impact factor: 4.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.